Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Travere Therapeutics, Inc.(TVTX) | 0 | 145,000 | +145,000 | $0 | $8.54M | 7.14% | +$8.54M |
| Cytokinetics, Incorporated(CYTK) | 0 | 128,000 | +128,000 | $0 | $8.44M | 7.06% | +$8.44M |
| BridgeBio Pharma, Inc.(BBIO) | 0 | 100,000 | +100,000 | $0 | $6.58M | 5.51% | +$6.58M |
| Acadia Pharmaceuticals Inc | 0 | 320,000 | +320,000 | $0 | $6.45M | 5.40% | +$6.45M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 0 | 70,000 | +70,000 | $0 | $5.50M | 4.60% | +$5.50M |
| PTC Therapeutics, Inc.(PTCT) | 0 | 80,000 | +80,000 | $0 | $5.18M | 4.34% | +$5.18M |
| Praxis Precision Medicines, Inc.(PRAX) | 0 | 17,000 | +17,000 | $0 | $4.95M | 4.14% | +$4.95M |
| Vera Therapeutics, Inc.CL A(VERA) | 0 | 150,000 | +150,000 | $0 | $4.84M | 4.05% | +$4.84M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 0 | 180,000 | +180,000 | $0 | $4.76M | 3.98% | +$4.76M |
| Annexon Inc | 0 | 1,120,000 | +1,120,000 | $0 | $4.74M | 3.96% | +$4.74M |
| United Therapeutics Corporation(UTHR) | 0 | 8,000 | +8,000 | $0 | $4.34M | 3.63% | +$4.34M |
| NewAmsterdam Pharma Company N.V.(NAMS) | 0 | 160,000 | +160,000 | $0 | $3.89M | 3.26% | +$3.89M |
| Xeris Biopharma Holdings Inc | 0 | 400,000 | +400,000 | $0 | $3.82M | 3.20% | +$3.82M |
| Celcuity Inc.(CELC) | 0 | 48,000 | +48,000 | $0 | $3.82M | 3.19% | +$3.82M |
| Dbv Technologies S AADS | 0 | 270,000 | +270,000 | $0 | $3.18M | 2.66% | +$3.18M |
| Viridian Therapeutics, Inc.(VRDN) | 0 | 150,000 | +150,000 | $0 | $3.09M | 2.58% | +$3.09M |
| Zentalis Pharmaceuticals Inc | 0 | 1,080,000 | +1,080,000 | $0 | $2.99M | 2.50% | +$2.99M |
| BioMarin Pharmaceutical Inc.(BMRN) | 0 | 48,000 | +48,000 | $0 | $2.88M | 2.41% | +$2.88M |
| Biogen Inc.(BIIB) | 0 | 12,000 | +12,000 | $0 | $2.71M | 2.27% | +$2.71M |
| Mineralys Therapeutics, Inc.(MLYS) | 0 | 100,000 | +100,000 | $0 | $2.51M | 2.10% | +$2.51M |
| Ligand Pharmaceuticals Incorporated(LGND) | 0 | 8,000 | +8,000 | $0 | $2.50M | 2.09% | +$2.50M |
| Ultragenyx Pharmaceutical Inc.(RARE) | 0 | 160,000 | +160,000 | $0 | $2.40M | 2.01% | +$2.40M |
| Vaxcyte, Inc.(PCVX) | 0 | 40,000 | +40,000 | $0 | $2.28M | 1.90% | +$2.28M |
| Oric Pharmaceuticals Inc | 0 | 160,000 | +160,000 | $0 | $2.16M | 1.80% | +$2.16M |
| Axsome Therapeutics, Inc.(AXSM) | 0 | 10,000 | +10,000 | $0 | $1.84M | 1.54% | +$1.84M |
| Silence Therapeutics plcADS(SLN) | 0 | 160,000 | +160,000 | $0 | $1.75M | 1.46% | +$1.75M |
| Beam Therapeutics Inc.(BEAM) | 0 | 70,000 | +70,000 | $0 | $1.71M | 1.43% | +$1.71M |
| Biohaven Ltd.(BHVN) | 0 | 120,000 | +120,000 | $0 | $1.60M | 1.34% | +$1.60M |
| Contineum Therapeutics IncCL A | 0 | 108,000 | +108,000 | $0 | $1.45M | 1.21% | +$1.45M |
| Genmab A/SADS(GMAB) | 0 | 40,000 | +40,000 | $0 | $1.43M | 1.19% | +$1.43M |
| Neurocrine Biosciences, Inc.(NBIX) | 0 | 8,000 | +8,000 | $0 | $1.13M | 0.95% | +$1.13M |
| Monopar Therapeutics Inc | 0 | 12,000 | +12,000 | $0 | $956.0K | 0.80% | +$956.0K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 80,000 | +80,000 | $0 | $936.0K | 0.78% | +$936.0K |
| Ars Pharmaceuticals Inc | 0 | 200,000 | +200,000 | $0 | $862.0K | 0.72% | +$862.0K |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 16,000 | +16,000 | $0 | $714.4K | 0.60% | +$714.4K |
| Olema Pharmaceuticals Inc | 0 | 80,000 | +80,000 | $0 | $691.2K | 0.58% | +$691.2K |
| Lexicon Pharmaceuticals Inc | 0 | 320,000 | +320,000 | $0 | $600.0K | 0.50% | +$600.0K |
| Wave Life Sciences IncSHS | 0 | 160,000 | +160,000 | $0 | $592.0K | 0.50% | +$592.0K |
| Savara Inc.(SVRA) | 0 | 80,000 | +80,000 | $0 | $412.8K | 0.35% | +$412.8K |
| Gossamer Bio Inc | 0 | 24,000 | +24,000 | $0 | $284.4K | 0.24% | +$284.4K |